Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CCR4 | P51679 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19087403 | 0.83 | RAPGEF4 (0.53) | TAS2R14TP53ALDH1A1KMT2AMEN1 | |
| SCHEMBL24255017 | 0.83 | TAS2R14 (0.41) | TAS2R14ALDH1A1LMNAP2RX7PPARG | |
| SCHEMBL22743371 | 0.83 | HSD17B2 (0.46) | TAS2R14ALDH1A1LMNAP2RX7PPARG | |
| SCHEMBL19087556 | 0.82 | RAPGEF4 (0.50) | TAS2R14TP53ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL23927543 | 0.80 | CSNK1D (0.47) | ALDH1A1LMNAKMT2AMEN1TDP1 | |
| SCHEMBL30719048 | 0.80 | CSNK1D (0.47) | ALDH1A1LMNAKMT2AMEN1TDP1 | |
| SCHEMBL4901952 | 0.79 | P2RX7 (0.46) | TP53SLC2A1ALDH1A1CCR4SMN1; SMN2 | |
| SCHEMBL12320144 | 0.79 | CSNK1D (0.39) | TAS2R14TP53SLC2A1ALDH1A1LMNA | |
| SCHEMBL24318836 | 0.78 | P2RX7 (0.45) | TP53SLC2A1ALDH1A1CCR4SMN1; SMN2 | |
| SCHEMBL12320134 | 0.77 | GAA (0.45) | TP53SLC2A1ALDH1A1SMN1; SMN2P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110249030-B | Organic electroluminescent device | 材料科学有限公司 | 2023-04-18 | — | — | CN | disclosed |
| US-20200377513-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2020-12-03 | — | — | US | disclosed |
| US-20200377513-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2020-12-03 | — | — | US | disclosed |
| US-20190006592-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | MATERIAL SCIENCE CO., LTD. (KR) | 2019-01-03 | — | — | US | disclosed |
| WO-2018128470-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | 머티어리얼사이언스 주식회사 | 2018-07-12 | — | — | WO | disclosed |
| EP-2635274-B1 | ANTI-STAPHYLOCOCCAL CELECOXIB DERIVATIVES | UNIV OHIO STATE RES FOUND (US) | 2017-12-06 | — | — | EP | disclosed |
| WO-2017116169-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | 머티어리얼사이언스 주식회사 | 2017-07-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190006592-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | OCIAD1, OCIAD2, ORC3 | TAS2R14 2750/4885TP53 1330/4885SLC2A1 4641/4885 |
| US-20200377513-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | PIEZO1, TMEM109, LEF1 | TAS2R14 1401/4885TP53 4575/4885SLC2A1 2517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.